Companies / Nex-i
Nex-i
Seoul, South Korea
Nex-i develops cancer therapies, including ADC technology and immune anticancer drugs.
Nex-i, based in Seoul, South Korea, has 2 investors on file, among them Atinum Investment and Schmidt. Its site was last checked 20 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Atinum Investment
243 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (30%), AI & Machine Learning (13%), Semiconductors & Electronics (10%).
See Atinum Investment's full profile · Who invests alongside it
More from Schmidt
62 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (24%), AI & Machine Learning (19%), Climate & Energy (16%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Nex-i and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atinum Investment adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/nex-i.co.kr/investors
# also
GET /v1/companies/nex-i.co.kr
GET /v1/companies/nex-i.co.kr/news